D. Vlodavets

1.3k total citations · 1 hit paper
52 papers, 454 citations indexed

About

D. Vlodavets is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, D. Vlodavets has authored 52 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 31 papers in Genetics and 14 papers in Surgery. Recurrent topics in D. Vlodavets's work include Neurogenetic and Muscular Disorders Research (31 papers), RNA modifications and cancer (16 papers) and Muscle Physiology and Disorders (12 papers). D. Vlodavets is often cited by papers focused on Neurogenetic and Muscular Disorders Research (31 papers), RNA modifications and cancer (16 papers) and Muscle Physiology and Disorders (12 papers). D. Vlodavets collaborates with scholars based in Russia, Switzerland and United States. D. Vlodavets's co-authors include Pierre G. Carlier, Olivier Scheidegger, Benjamin Marty, Pierre‐Yves Baudin, Paulo Loureiro de Sousa, Eduard Snezhko, Ksenija Gorni, Laurent Servais, R. Scalco and Riccardo Masson and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

D. Vlodavets

37 papers receiving 449 citations

Hit Papers

Risdiplam-Treated Infants with Type 1 Spinal Muscular Atr... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls
    2021 160 citations Basil T. Darras, Maria Mazurkiewicz-Bełdzińska et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Vlodavets Russia 9 267 265 166 50 49 52 454
Louise Otto Netherlands 13 511 1.9× 285 1.1× 352 2.1× 69 1.4× 101 2.1× 18 663
Ziga Cizman United States 7 188 0.7× 287 1.1× 95 0.6× 64 1.3× 23 0.5× 19 492
Marco Pelliccioni Italy 7 440 1.6× 427 1.6× 250 1.5× 13 0.3× 78 1.6× 8 665
Andreas Totzeck Germany 13 249 0.9× 391 1.5× 158 1.0× 8 0.2× 30 0.6× 28 677
Simon Witzel Germany 13 239 0.9× 172 0.6× 114 0.7× 21 0.4× 20 0.4× 23 393
L. Dewar United Kingdom 6 66 0.2× 200 0.8× 30 0.2× 45 0.9× 35 0.7× 10 325
Sithara Ramdas United Kingdom 10 128 0.5× 118 0.4× 91 0.5× 7 0.1× 12 0.2× 39 367
Brigitte Estournet-Mathiaud France 10 180 0.7× 127 0.5× 131 0.8× 5 0.1× 21 0.4× 18 309
Berthold Schrank Germany 6 293 1.1× 279 1.1× 139 0.8× 4 0.1× 14 0.3× 10 436
A. Jacobs Belgium 5 125 0.5× 88 0.3× 147 0.9× 62 1.2× 23 0.5× 7 353

Countries citing papers authored by D. Vlodavets

Since Specialization
Citations

This map shows the geographic impact of D. Vlodavets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Vlodavets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Vlodavets more than expected).

Fields of papers citing papers by D. Vlodavets

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Vlodavets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Vlodavets. The network helps show where D. Vlodavets may publish in the future.

Co-authorship network of co-authors of D. Vlodavets

This figure shows the co-authorship network connecting the top 25 collaborators of D. Vlodavets. A scholar is included among the top collaborators of D. Vlodavets based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Vlodavets. D. Vlodavets is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Белоусова, Е. Д., et al.. (2025). Functional class criteria identification in patients with spinal muscular atrophy 5q. SHILAP Revista de lepidopterología. 14(4). 58–70.
2.
Павликова, Е.П., et al.. (2024). Sleep Disorders and Fatigue in Patients with Different Forms of Myotonic Dystrophy Type 1. Neuroscience and Behavioral Physiology. 54(1). 35–40. 1 indexed citations
3.
Курбатов, С. В., et al.. (2024). Cognitive and emotional disturbances in adult patients with myotonic dystrophy type 1. SHILAP Revista de lepidopterología. 14(2).
4.
5.
Vlodavets, D., et al.. (2024). The functional state of the respiratory system of the patients with proximal spinal muscular atrophy 5q (SMA 5q): from the natural history of the disease to the era of pathogenetic therapy. Problems and expectations. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 69(4). 16–30.
6.
Vlodavets, D., et al.. (2024). SMArt Retro study: a retrospective data analysis of the Russian registry of patients with spinal muscular atrophy. SHILAP Revista de lepidopterología. 14(3). 54–71. 1 indexed citations
7.
Vlodavets, D., et al.. (2023). Clinical characteristics of different forms of myotonic dystrophy type 1. SHILAP Revista de lepidopterología. 18(1). 22–37.
8.
Павликова, Е.П., et al.. (2023). Sleep disorders and fatigue in patients with different forms of myotonic dystrophy type 1. S S Korsakov Journal of Neurology and Psychiatry. 123(8). 62–62. 1 indexed citations
9.
Darras, Basil T., Giovanni Baranello, Odile Boespflug‐Tanguy, et al.. (2023). FIREFISH Parts 1 and 2: 36-month safety and efficacy of risdiplam in Type 1 spinal muscular atrophy (SMA) (P7-9.009). Neurology. 100(17_supplement_2). 1 indexed citations
10.
Vlodavets, D., et al.. (2023). Pilot Program of Newborn Screening for 5q Spinal Muscular Atrophy in the Russian Federation. International Journal of Neonatal Screening. 9(2). 29–29. 7 indexed citations
11.
Vlodavets, D., et al.. (2022). Experience of using gene replacement therapy with Zolgensma® (onasemnogene abeparvovec) in real clinical practice in Russia. SHILAP Revista de lepidopterología. 12(1). 29–38. 8 indexed citations
12.
Vlodavets, D., et al.. (2021). Retrospective analysis of the natural history of type 1 spinal muscular atrophy in children. SHILAP Revista de lepidopterología. 66(4). 64–73. 1 indexed citations
13.
Artemieva, Svetlana, et al.. (2020). The efficacy and safety of nusinersen within the expanded access program in Russia. SHILAP Revista de lepidopterología. 10(3). 35–41. 3 indexed citations
14.
Заваденко, Н. Н. & D. Vlodavets. (2020). L.O. Badalyan and current progress in the study of hereditary neuromuscular diseases. 1(1). 64–72. 1 indexed citations
15.
Vlodavets, D., et al.. (2020). CARDIOVASCULAR SYSTEM LESION CAUSED BY PROGRESSIVE DUCHENNE MUSCULAR DYSTROPHY: PECULIARITIES OF DIAGNOSIS, OBSERVATION AND TREATMENT. PEDIATRIA Journal named after G N SPERANSKY. 99(3). 95–102.
16.
Reshetov, Denis A., Svetlana G. Vassilieva, D. Vlodavets, et al.. (2019). CRISPR/Cas9-generated mouse model of Duchenne muscular dystrophy recapitulating a newly identified large 430 kb deletion in the human DMD gene. Disease Models & Mechanisms. 12(4). 30 indexed citations
17.
Reshetov, Denis A., et al.. (2016). Analysis of phenotype expressions of deletions in the dystrophin gene in terms of efficiency of exon skipping as a method for treatment of hereditary dystrophinopathies. Bulletin of Russian State Medical University. 21–26. 1 indexed citations
18.
Белоусова, Е. Д., et al.. (2016). Targeted therapy for tuberous sclerosis complex. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 61(5). 106–112. 2 indexed citations
19.
Carlier, Pierre G., Benjamin Marty, Olivier Scheidegger, et al.. (2016). Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials. Journal of Neuromuscular Diseases. 3(1). 1–28. 136 indexed citations
20.
Reshetov, Denis A., et al.. (2016). Modification of the method for analysis of genome editing results using CRISPR/Cas9 system on preimplantation mouse embryos. Bulletin of Russian State Medical University. 15–20. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louise Otto Breakdown of academic impact, for papers by Ziga Cizman Breakdown of academic impact, for papers by Marco Pelliccioni Breakdown of academic impact, for papers by Andreas Totzeck Breakdown of academic impact, for papers by Simon Witzel Breakdown of academic impact, for papers by L. Dewar Breakdown of academic impact, for papers by Sithara Ramdas Breakdown of academic impact, for papers by Brigitte Estournet-Mathiaud Breakdown of academic impact, for papers by Berthold Schrank Breakdown of academic impact, for papers by A. Jacobs
Rankless by CCL
2026